We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$61.6M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$32.2M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$21.8M
4
USO icon
United States Oil Fund
USO
+$12.8M
5
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$11.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNLN icon
4726
Greenlane Holdings
GNLN
$1.21M
– –
0
– –
NVDL icon
4727
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.82B
$4.15K ﹤0.01%
+300
New +$2.91K
CLRO icon
4728
ClearOne Inc
CLRO
$15.1M
$4.14K ﹤0.01%
151
-347
-70% -$6.11K
ATLO icon
4729
AMES National
ATLO
$277M
$4.14K ﹤0.01%
205
-335
-62% -$6.57K
MACK
4730
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4.14K ﹤0.01%
280
-986
-78% -$13.9K
APYX icon
4731
Apyx Medical
APYX
$126M
$4.13K ﹤0.01%
3,040
-1,095
-26% -$2.33K
FMED icon
4732
Fidelity Disruptive Medicine ETF
FMED
$48.5M
$4.13K ﹤0.01%
162
– –
CWEB icon
4733
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$236M
$4.13K ﹤0.01%
138
-514
-79% -$14.5K
ONEQ icon
4734
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
$4.12K ﹤0.01%
64
-766
-92% -$47.4K
GPRO icon
4735
GoPro
GPRO
$109M
$4.12K ﹤0.01%
1,848
-21,934
-92% -$58.6K
KAVL
4736
DELISTED
Kaival Brands Innovations Group
KAVL
$4.11K ﹤0.01%
1,418
+879
+163% +$2.48K
MUJ icon
4737
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$653M
$4.11K ﹤0.01%
+353
New +$4.06K
FIEE
4738
FiEE Inc
FIEE
$34.8M
$4.1K ﹤0.01%
644
-2,201
-77% -$9.69K
ATRA icon
4739
Atara Biotherapeutics
ATRA
$80.9M
$4.1K ﹤0.01%
236
-576
-71% -$10.2K
OLB icon
4740
OLB
OLB
$4.4M
$4.09K ﹤0.01%
716
-56
-7% -$416
OSA
4741
DELISTED
ProSomnus, Inc. Common Stock
OSA
$4.08K ﹤0.01%
7,164
+492
+7% +$339
DJP icon
4742
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$824M
$4.07K ﹤0.01%
131
– –
MFIN icon
4743
Medallion Financial
MFIN
$252M
$4.07K ﹤0.01%
+515
New +$4.63K
DXYN
4744
DELISTED
Dixie Group Inc
DXYN
$4.06K ﹤0.01%
7,166
-7
-0.1% -$4
TERN
4745
DELISTED
Terns Pharmaceuticals
TERN
$4.06K ﹤0.01%
619
-22,377
-97% -$146K
YTEN
4746
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$4.05K ﹤0.01%
444
+15
+3% +$94
GROY icon
4747
Gold Royalty Corp
GROY
$725M
$4.05K ﹤0.01%
+2,154
New +$3.46K
IBIT icon
4748
iShares Bitcoin Trust
IBIT
$47.2B
$4.05K ﹤0.01%
+100
New +$3.12K
BKT icon
4749
BlackRock Income Trust
BKT
$341M
$4.05K ﹤0.01%
340
-87
-20% -$1.04K
MSEX icon
4750
Middlesex Water
MSEX
$1.1B
$4.04K ﹤0.01%
77
-8,120
-99% -$449K
188 189
190
191 192

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.